8HEJ
Crystal structure of Transthyretin in complex with a covalent inhibitor trans-styrylpyrazole
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | PAL/PLS BEAMLINE 7A (6B, 6C1) |
Synchrotron site | PAL/PLS |
Beamline | 7A (6B, 6C1) |
Temperature [K] | 80 |
Detector technology | CCD |
Collection date | 2021-12-22 |
Detector | ADSC QUANTUM 270 |
Wavelength(s) | 0.9792 |
Spacegroup name | P 21 21 2 |
Unit cell lengths | 84.945, 42.685, 64.272 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 30.107 - 1.540 |
R-factor | 0.1875 |
Rwork | 0.186 |
R-free | 0.22330 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3hj0 |
RMSD bond length | 0.011 |
RMSD bond angle | 1.162 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHENIX |
Refinement software | PHENIX (1.14) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 1.450 |
High resolution limit [Å] | 1.400 | 1.400 |
Number of reflections | 88572 | 88572 |
<I/σ(I)> | 48.7 | |
Completeness [%] | 99.9 | |
Redundancy | 14.2 | |
CC(1/2) | 0.999 | 0.868 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 292 | Sodium Citrate pH5.5, Glycerol |